ATE404245T1 - Pharmazeutische zusammensetzung enthaltend einen künstlichen sauerstoffträger - Google Patents

Pharmazeutische zusammensetzung enthaltend einen künstlichen sauerstoffträger

Info

Publication number
ATE404245T1
ATE404245T1 AT04008419T AT04008419T ATE404245T1 AT E404245 T1 ATE404245 T1 AT E404245T1 AT 04008419 T AT04008419 T AT 04008419T AT 04008419 T AT04008419 T AT 04008419T AT E404245 T1 ATE404245 T1 AT E404245T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
composition containing
osmotic pressure
oxygen carrier
artificial oxygen
Prior art date
Application number
AT04008419T
Other languages
English (en)
Inventor
Toshiya Kai
Naohisa Katayama
Yuko Azuma
Junichi Yokoe
Yoshinori Kida
Ippei Hukutomi
Makoto Sato
Eishun Tsuchida
Shinji Takeoka
Teruyuki Komatsu
Hiromi Sakai
Keitaro So
Original Assignee
Nipro Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nipro Corp filed Critical Nipro Corp
Application granted granted Critical
Publication of ATE404245T1 publication Critical patent/ATE404245T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026Blood substitute; Oxygen transporting formulations; Plasma extender
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10Preservation of living parts
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10Preservation of living parts
    • A01N1/12Chemical aspects of preservation
    • A01N1/122Preservation or perfusion media
    • A01N1/126Physiologically active agents, e.g. antioxidants or nutrients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41Porphyrin- or corrin-ring-containing peptides
    • A61K38/42Haemoglobins; Myoglobins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04008419T 2003-04-08 2004-04-07 Pharmazeutische zusammensetzung enthaltend einen künstlichen sauerstoffträger ATE404245T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003103875A JP2004307404A (ja) 2003-04-08 2003-04-08 人工酸素運搬体を含む医薬組成物

Publications (1)

Publication Number Publication Date
ATE404245T1 true ATE404245T1 (de) 2008-08-15

Family

ID=32866721

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04008419T ATE404245T1 (de) 2003-04-08 2004-04-07 Pharmazeutische zusammensetzung enthaltend einen künstlichen sauerstoffträger

Country Status (6)

Country Link
US (1) US7417118B2 (de)
EP (1) EP1466649B1 (de)
JP (1) JP2004307404A (de)
AT (1) ATE404245T1 (de)
DE (1) DE602004015660D1 (de)
ES (1) ES2308061T3 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8304181B2 (en) 2004-10-07 2012-11-06 Transmedics, Inc. Method for ex-vivo organ care and for using lactate as an indication of donor organ status
CN103931605B (zh) 2004-10-07 2015-11-18 特兰斯迈迪茨公司 用于活体外器官护理的系统和方法
US12010987B2 (en) 2004-10-07 2024-06-18 Transmedics, Inc. Systems and methods for ex-vivo organ care and for using lactate as an indication of donor organ status
US20060166861A1 (en) * 2005-01-25 2006-07-27 Yoshinori Kida Inclusion compound of porphyrin metal complex and albumin
JP2006232818A (ja) * 2005-01-25 2006-09-07 Nipro Corp ポルフィリン金属錯体とアルブミンとの包接化合物
US8647613B2 (en) 2005-03-16 2014-02-11 Jcr Pharmaceuticals Co., Ltd. Drug carrier
JP5038128B2 (ja) * 2005-03-16 2012-10-03 日本ケミカルリサーチ株式会社 薬物運搬体
US9078428B2 (en) * 2005-06-28 2015-07-14 Transmedics, Inc. Systems, methods, compositions and solutions for perfusing an organ
DE102005031532A1 (de) * 2005-07-01 2007-01-04 Cytonet Gmbh & Co. Kg Lagermedium für Zellen
TW200727900A (en) * 2005-07-27 2007-08-01 Yakult Honsha Kk Aqueous solution preparation containing camptothecins
WO2007094511A1 (ja) * 2006-02-15 2007-08-23 Oxygenix Co., Ltd. ヘモグロビンベース酸素運搬体を用いた動物細胞の培養方法
IL181126A0 (en) * 2006-11-01 2007-07-04 S B Biotechnologies Ltd Preparation of gold-containing nano-liposome particles and their use in medical therapy
WO2008074851A2 (en) * 2006-12-19 2008-06-26 Nokad Method for inhibiting the expression of endogenous erythropoietin (epo)
JP2008195656A (ja) * 2007-02-14 2008-08-28 Nipro Corp 人工酸素運搬体製剤
US9457179B2 (en) 2007-03-20 2016-10-04 Transmedics, Inc. Systems for monitoring and applying electrical currents in an organ perfusion system
EP2058398A1 (de) 2007-11-09 2009-05-13 Nipro Corporation Herstellung von rekombinantem humanem Hämoglobin mittels Pichia-Hefe
US8618056B2 (en) 2007-12-22 2013-12-31 Cuthbert O. Simpkins Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
US8063020B2 (en) 2007-12-22 2011-11-22 Simpkins Cuthbert O Resuscitation fluid
US8906855B2 (en) 2007-12-22 2014-12-09 Vivacelle Bio, Inc. Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
US8420380B2 (en) 2008-01-31 2013-04-16 Transmedics, Inc. Systems and methods for ex vivo lung care
US20090253712A1 (en) * 2008-04-03 2009-10-08 Semmelweis Egyetem Aqueous solvent system for solubilization of azole compounds
US8420118B2 (en) * 2009-09-10 2013-04-16 The Board Of Regents Of The University Of Oklahoma Anionic lipids and lipid nano-structures and methods of producing and using same
US8808748B2 (en) * 2010-04-20 2014-08-19 Vindico NanoBio Technology Inc. Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same
US8889830B2 (en) 2011-03-01 2014-11-18 Chuo University Hemoglobin-albumin complex, and artificial plasma expander and artificial oxygen carrier containing the complex
US20130011823A1 (en) 2011-04-14 2013-01-10 Hassanein Waleed H Organ care solution for ex-vivo machine perfusion of donor lungs
JP2017518301A (ja) 2014-06-02 2017-07-06 トランスメディクス, インク.Transmedics, Inc. ex−vivoでの臓器管理システム
EP3200582B1 (de) 2014-09-29 2023-11-15 Fred Hutchinson Cancer Center Zusammensetzungen, kits und verfahren zur induktion von erworbener zytoresistenz durch stressproteininduktoren
CA3155169A1 (en) 2014-12-12 2016-06-16 Tevosol, Inc. Apparatus and method for organ perfusion
US11207421B2 (en) 2015-04-16 2021-12-28 The Research Foundation For The State University Of New York Nanostructures comprising cobalt porphyrin-phospholipid conjugates and polyhistidine-tags
EP3283056B3 (de) 2015-04-16 2022-04-06 The Research Foundation For The State University Of New York University at Buffalo Nanostrukturen mit kobaltporphyrin-phospholipid-konjugaten und polyhistidin-tags
US10456452B2 (en) 2015-07-02 2019-10-29 Poseida Therapeutics, Inc. Compositions and methods for improved encapsulation of functional proteins in polymeric vesicles
CA2997267A1 (en) 2015-09-09 2017-03-16 Transmedics, Inc. Aortic cannula for ex vivo organ care system
US11213594B2 (en) 2016-04-29 2022-01-04 Poseida Therapeutics, Inc. Poly(histidine)-based micelles for complexation and delivery of proteins and nucleic acids
WO2017201447A1 (en) 2016-05-19 2017-11-23 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Reduced oxygen carriers and their use for the treatment of carboxyhemoglobinemia
ES2968062T3 (es) 2016-05-30 2024-05-07 Transmedics Inc Aparato y método de ventilación pulmonar ex vivo con presión exterior variable
WO2021230261A1 (ja) * 2020-05-11 2021-11-18 国立大学法人大阪大学 刺激に応答して酸素を放出する系

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US120096A (en) * 1871-10-17 Improvement in making rubber stereotypes
GB1578776A (en) * 1976-06-10 1980-11-12 Univ Illinois Hemoglobin liposome and method of making the same
JPS6033367B2 (ja) 1978-11-24 1985-08-02 株式会社ミドリ十字 酸素運搬輸液
JPS57206622A (en) 1981-06-10 1982-12-18 Ajinomoto Co Inc Blood substitute
US4425334A (en) * 1982-04-02 1984-01-10 The Regents Of The University Of California Functional oxygen transport system
JPS58213711A (ja) * 1982-06-07 1983-12-12 Hidetoshi Tsuchida 鉄(2)ポルフイリン錯体を包接したリポソ−ムおよび酸素吸脱着剤
US4530926A (en) * 1982-06-29 1985-07-23 The Green Cross Corporation Perfluorotricyclic amines as oxygen carriers
JPS6137735A (ja) 1984-07-31 1986-02-22 Terumo Corp ヘモグロビン含有リポソ−ムおよびその製造方法
JPH0720857B2 (ja) 1988-08-11 1995-03-08 テルモ株式会社 リポソームおよびその製法
JP3037994B2 (ja) 1989-11-02 2000-05-08 テルモ株式会社 リポソーム表面への蛋白質吸着抑制剤
JP3085963B2 (ja) 1990-04-24 2000-09-11 テルモ株式会社 人工血液
US5589189A (en) * 1994-09-14 1996-12-31 Nexstar Pharmaceuticals, Inc. Liposome dispersion
WO1998008500A1 (en) 1996-08-26 1998-03-05 Board Of Regents, The University Of Texas System Hypertonic arginine compositions and methods
JP3181276B2 (ja) 1999-08-31 2001-07-03 科学技術振興事業団 樹枝状分岐構造を持つ両親媒性化合物

Also Published As

Publication number Publication date
EP1466649A1 (de) 2004-10-13
US7417118B2 (en) 2008-08-26
EP1466649B1 (de) 2008-08-13
DE602004015660D1 (de) 2008-09-25
ES2308061T3 (es) 2008-12-01
JP2004307404A (ja) 2004-11-04
US20040258745A1 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
ATE404245T1 (de) Pharmazeutische zusammensetzung enthaltend einen künstlichen sauerstoffträger
TR200201921T2 (tr) İyileştirilmiş pediyatrik formülasyon ve beslenme temin etmek ve tolerans geliştirmek için yöntemler.
DE60220174D1 (de) Herbizidzusammensetzungen umfassend imidazolinonsäure
CO5570656A2 (es) Liberacin controlada de una sustancia activa a un entorno rico en grasa
EP1100522A4 (de) Verabreichung aktiver wirkstoffe über die lunge
ATE464057T1 (de) Gepufferte dialyselösung
DE602005014393D1 (de) Stabile pharmazeutische zusammensetzungen aus antitumoralen platin-(ii)-mitteln
ITMI20020189A1 (it) Composizione per uso farmaceutico o dietetico per contrastare la caduta dei capelli
DK1295600T3 (da) Lægemiddel baseret på gestagener til dermal anvendelse indeholdende ascorbinsyre og/eller salte deraf
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
CL2004000954A1 (es) Composicion parasiticida en animales que contiene flumetrina y mkg 264 (n-octil biciclohepteno dicarboxamida) en una relacion en peso de al menos 1:20, eventualmente otros principios activos vehiculos y coadyuvantes, y uso de la composicion para prep
GEP20094620B (en) Irinotecan preparation
BR0307935A (pt) Sais de trans carotenóide bipolares e seus usos
AR059113A1 (es) Composicion para administracion topica
ATE367165T1 (de) Xanthangummi enthaltende reepithelialisierende pharmazeutische zubereitungen
ATE513555T1 (de) Pharmazeutische kombination aus g-csf und plgf für blutstammzellen
BR9914644A (pt) Composições tamponadas para diálise
KR950032165A (ko) 토코페롤 유도체
IS8430A (is) Lyf sem inniheldur (2R)-2-própýloktansýru sem virka efnisþáttinn
ITMI20022549A1 (it) Composizione quaternaria comprendente come sostanza attiva la propolis.
UY27373A1 (es) Formulaciones de interferón beta-humano
CA2534565A1 (en) Reconstitution medium for protein and peptide formulations
BR9714279A (pt) Preparação aquosa, e, uso da mesma.
EP1552838A4 (de) Rubrofusarin-glycosid-haltige zusammensetzung
KR20150010550A (ko) 구강 케어용 조성물

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties